Daniel F. Hayes, MD, FASCO, has been elected president of the American Society of Clinical Oncology.
Daniel F. Hayes, MD, FASCO, has been elected president of the American Society of Clinical Oncology (ASCO) for the term beginning in June 2016. He will take office as president-elect during the ASCO Annual Meeting in Chicago in June 2015. Additionally, 4 new members were elected to the ASCO Board of Directors and 2 new members to the ASCO Nominating Committee.
“I’m honored to be elected incoming president of ASCO, which has had such a major influence on my professional career,” said Dr Hayes. “I look forward to working with ASCO leadership and staff on the critical initiatives within the oncology community including new strategies for health care reform; the development of CancerLinQ; efforts to improve value in cancer care; personalized cancer care; and reducing global disparities in cancer treatment. ASCO is uniquely positioned to tackle these issues head-on, and I look forward to being part of this exciting time in the life of the Society.”
Link to the complete press release: http://bit.ly/1GSXm7e
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Navigating the Mental Health Challenges of Cancer Diagnosis, Treatment, and Survivorship
March 12th 2024Stress has potential links to worse outcomes in cancer, such as decreased quality of life and greater risks of disease progression and metastasis. There is a complex mix of emotions patients with cancer experience.
Read More